NEXTBio Capital Management LP

SEC CIK: 0002038158
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

GPCR holding history

Structure Therapeutics Inc. in every 13F filed by NEXTBio Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GPCR overview All 13F holders of GPCR Full Q2 2026 holdings

Shares (Q2 2026): 312,496
Value: $16.8M
% of portfolio: 7.7%
Quarters held: 3; Since Q4 2025

Holdings of GPCR by NEXTBio Capital Management LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	312,496	$16.8M	7.7%	+179,257+134.5%	Added	Holders
Q1 2026	133,239	$6.42M	3.0%	+38,796+41.1%	Added	Holders
Q4 2025	94,443	$6.57M	3.9%	–	No prior filing	Holders